Fir Tree Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Fir Tree Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-199,000	Closed	-$2.08M	–	305
2023 Q1	$2.08M	Buy	199,000 +50,000	+34%	+$518K	0.16%	184
2022 Q4	$1.53M	Sell	149,000 -500	-0.3%	-$5.06K	0.08%	266
2022 Q3	$1.5M	Hold	149,500	–	–	0.05%	368
2022 Q2	$1.49M	Sell	149,500 -500	-0.3%	-$4.99K	0.05%	389
2022 Q1	$1.5M	Hold	150,000	–	–	0.04%	393
2021 Q4	$1.49M	Buy	+150,000	New	+$1.49M	0.04%	394

Fir Tree Capital Management's LVAC Position: Q2 2023 in Review

Fir Tree Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 199,000 shares — an estimated $2.08M sold.

Fir Tree Capital Management first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $2.08M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Fir Tree Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Fir Tree Capital Management sold 199,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.08M.
Fir Tree Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Fir Tree Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.08M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Fir Tree Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.